Income Taxes - Expense (Details) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Reconciliation of income tax expense | ||
| Federal statutory rate | 21.00% | 21.00% |
| Stock compensation | (0.47%) | (0.47%) |
| State taxes | 0.60% | (0.13%) |
| Research and development credit | 2.53% | 5.13% |
| Acquired in-process research and development | (8.09%) | 0.00% |
| Fair value adjustment to contingent consideration | 0.00% | 1.65% |
| NOL carryback due to CARES Act | 3.26% | 0.00% |
| Other | (0.16%) | (1.86%) |
| Valuation allowance | (14.46%) | (27.07%) |
| Effective income tax rate | 4.21% | (1.75%) |
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Built In Loss, Percent No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Change In Fair Value Of Contingent Consideration No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, NOL Carryback To CARES Act, Percent No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Net Operating Loss Adjustment Per Section 382, Percent No definition available.
|
| X | ||||||||||
- Definition Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) owing to permanent differences. No definition available.
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|